Patient-reported outcomes in relapsed/refractory multiple myeloma: a systematic review
作者: Francesco SparanoMichele CavoPasquale NiscolaTommaso CaravitaFabio Efficace
作者单位: 1Italian Group for Adult Hematologic Diseases (GIMEMA), Data Center and Health Outcomes Research Unit
2Institute of Hematology “L. and A. Seràgnoli”, Department of Experimental, Diagnostic and Specialty Medicine, “S.Orsola-Malpighi” University Hospital, University of Bologna
3Hematology Unit, S Eugenio Hospital
刊名: Supportive Care in Cancer, 2018, Vol.26 (7), pp.2075-2090
来源数据库: Springer Nature Journal
DOI: 10.1007/s00520-018-4137-x
关键词: Quality of lifePatient-reported outcomesRelapsedRefractoryMultiple myelomaAdverse events
英文摘要: Abstract(#br) Purpose(#br)We performed a systematic review to quantify the amount of evidence-based data available on patient-reported outcomes (PRO) in Relapsed/Refractory Multiple Myeloma (RRMM) patients and to examine the added value of such studies in supporting clinical decision-making.(#br) Methods(#br)We conducted a search in PubMed/Medline and the Cochrane Library to identify studies published between January 1990 and May 2017. All studies, regardless of the design, including patients with RRMM and also evaluating PRO were considered. For each study, we collected both PRO and traditional clinical outcomes, such as survival and toxicity information, based on a predefined data extraction form.(#br) Results(#br)After having screened 1680 records, 11 studies were identified and these...
全文获取路径: Springer Nature  (合作)
影响因子:2.649 (2012)